Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
VENT-03 by Ventus Therapeutics for Neuroinflammation: Likelihood of Approval
VENT-03 is under clinical development by Ventus Therapeutics and currently in Phase I for Neuroinflammation. According to GlobalData, Phase I...
VENT-03 by Ventus Therapeutics for Dermatomyositis: Likelihood of Approval
VENT-03 is under clinical development by Ventus Therapeutics and currently in Phase I for Dermatomyositis. According to GlobalData, Phase I...
VENT-03 by Ventus Therapeutics for Systemic Sclerosis (Scleroderma): Likelihood of Approval
VENT-03 is under clinical development by Ventus Therapeutics and currently in Phase I for Systemic Sclerosis (Scleroderma). According to GlobalData,...
VENT-03 by Ventus Therapeutics for Systemic Lupus Erythematosus: Likelihood of Approval
VENT-03 is under clinical development by Ventus Therapeutics and currently in Phase I for Systemic Lupus Erythematosus. According to GlobalData,...